Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $84.75 +3.91%
EPS Growth %: -96.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -96.6%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $19.7 million versus the consensus estimate of $18.36 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance
- onsemi to acquire Synaptics in $7 billion all-stock deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
